Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing
Medical Provider Experience Assessment Healthcare Decisions Post-Testing, Risk-Reducing, and Preventative Strategies Using LYNCH Genetic Testing
Sponsor: Data Collection Analysis Business Management
This observational or N/A phase trial investigates Colon Cancer and Endometrial Cancer and is currently ongoing. Data Collection Analysis Business Management leads this study, which shows 12 recorded versions since 2017 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Feb 2021 — Jul 2024 [monthly]
Unknown Status
Status: Enrolling By Invitation → Unknown Status
-
Jan 2021 — Feb 2021 [monthly]
Enrolling By Invitation
-
Feb 2019 — Jan 2021 [monthly]
Enrolling By Invitation
▶ Show 7 earlier versions
-
Nov 2018 — Feb 2019 [monthly]
Enrolling By Invitation
-
Oct 2018 — Nov 2018 [monthly]
Enrolling By Invitation
-
Sep 2018 — Oct 2018 [monthly]
Enrolling By Invitation
-
Jul 2018 — Sep 2018 [monthly]
Enrolling By Invitation
Status: Active Not Recruiting → Enrolling By Invitation
-
Jun 2018 — Jul 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Nov 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
First recorded
Oct 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Data Collection Analysis Business Management
- PAS Research Services
For direct contact, visit the study record on ClinicalTrials.gov .